Wanting Shao
P.R. China
Hangzhou, 310003, China
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Atypical ultrasonic manifestation of dermatofibrosarcoma protuberans in a female patient: a case report of hyperechoic type and reflection on diagnosis and treatment.
Journal: BMC women's health
Published: November 07, 2025
Favorable outcome of immunotherapy use in metastatic HR+/HER2- breast cancer: a population-based cohort study.
Journal: International journal of surgery (London, England)
Published: July 09, 2025
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: July 16, 2021
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: March 23, 2021
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer.
Journal: International journal of molecular sciences
Published: November 25, 2019
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.
Journal: Journal of translational medicine
Published: August 30, 2019
Pursuing shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS) for concomitant detection of breast lesions and microcalcifications.
Journal: Nanoscale
Published: September 30, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026